TI
AURA icon

Trexquant Investment’s Aura Biosciences AURA Stock Holding History

Trexquant Investment’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,998
Closed -$140K – 1889
2026
Q1 		$140K Sell
20,998
-22,000
-51% -$126K ﹤0.01% 1690
2025
Q4 		$234K Buy
+42,998
New +$255K ﹤0.01% 1496
2024
Q2 		– Sell
-12,204
Closed -$95.8K – 1507
2024
Q1 		$95.8K Sell
12,204
-5,158
-30% -$42.8K ﹤0.01% 1387
2023
Q4 		$154K Buy
17,362
+6,809
+65% +$57.7K ﹤0.01% 1350
2023
Q3 		$94.7K Buy
+10,553
New +$114K ﹤0.01% 1395

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Trexquant Investment's AURA Position: Q2 2026 in Review

Trexquant Investment sold out of Aura Biosciences (AURA) in Q2 2026, closing a stake of 20,998 shares — an estimated $140K sold.

Trexquant Investment first reported a position in AURA in Q3 2023 and held it in 5 quarters. The position peaked at $234K in Q4 2025. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Trexquant Investment reported no remaining Aura Biosciences position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 20,998 Aura Biosciences shares in Q2 2026, an estimated $140K.
  • Trexquant Investment first reported a position in Aura Biosciences in Q3 2023 and held it in 5 quarters.
  • Trexquant Investment's Aura Biosciences position peaked at $234K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.